Investigating personal and clinical recovery processes in people with first episode psychosis
SF Austin, C Hjorthøj, H Baagland… - Early intervention in …, 2022 - Wiley Online Library
Introduction Schizophrenia is a serious mental illness characterized by a range of symptoms
such as distortions in reality, emotional abnormalities and deficits in cognition. Recovery …
such as distortions in reality, emotional abnormalities and deficits in cognition. Recovery …
The course of neurocognitive changes in acute psychosis: relation to symptomatic improvement
Introduction Cognitive impairment is a core aspect of psychosis, but the course of cognitive
functioning during acute psychosis remains poorly understood, as does the association …
functioning during acute psychosis remains poorly understood, as does the association …
Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6 …
L Morrison, D Lin, C Benson, I Ghelerter… - Journal of Managed …, 2023 - jmcp.org
BACKGROUND: Among patients with schizophrenia, nonadherence to oral atypical
antipsychotics (OAAs) leads to increased risk of relapses, which entails substantial …
antipsychotics (OAAs) leads to increased risk of relapses, which entails substantial …
The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning
R Rodriguez-Jimenez, M Dompablo, A Bagney… - Schizophrenia …, 2015 - Elsevier
Abstract The MATRICS Consensus Cognitive Battery (MCCB) was administered to 293
schizophrenia outpatients and 210 community residents in Spain. Our first objective was to …
schizophrenia outpatients and 210 community residents in Spain. Our first objective was to …
[HTML][HTML] Association of cognitive performance with clinical staging in schizophrenia spectrum disorders: a prospective 6-year follow-up study
S Berendsen, E Nummenin, F Schirmbeck… - Schizophrenia Research …, 2022 - Elsevier
Background Clinical staging has been developed to capture the large heterogeneity in
schizophrenia spectrum disorders. Including cognitive performance in the staging model …
schizophrenia spectrum disorders. Including cognitive performance in the staging model …
20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes
M Starzer, HG Hansen, C Hjorthøj, N Albert… - Psychological …, 2024 - cambridge.org
BackgroundCognitive deficits are a core feature of schizophrenia and are closely associated
with poor functional outcomes. It remains unclear if cognitive deficits progress over time or …
with poor functional outcomes. It remains unclear if cognitive deficits progress over time or …
Do clinical characteristics predict the cognitive course in early‐onset schizophrenia‐spectrum disorders?
CM Teigset, C Mohn, C Brunborg… - Journal of Child …, 2018 - Wiley Online Library
Background Being in a period with extensive brain maturation, adolescents with early‐onset
schizophrenia‐spectrum disorders (EOS) provide unique neurodevelopmental data that may …
schizophrenia‐spectrum disorders (EOS) provide unique neurodevelopmental data that may …
Comparing the pharmacology and pharmacokinetics of antipsychotics: Choosing an antipsychotic and dosing a long-acting injectable
SM Stahl, G Djokic - European Neuropsychopharmacology, 2023 - Elsevier
In this paper, we will discuss the pharmacologic properties of antipsychotics, including those
that are the same in structure and those that differentiate one from another. We will bring to …
that are the same in structure and those that differentiate one from another. We will bring to …
Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization
C Wu, P Dagg, C Molgat - Psychiatry Research, 2017 - Elsevier
Cognitive impairment is a core feature of schizophrenia. Measuring the stability of cognitive
impairment is important for further understanding of this disorder. The Montreal Cognitive …
impairment is important for further understanding of this disorder. The Montreal Cognitive …
Leveraging genome-wide association and clinical data in revealing schizophrenia subgroups
Schizophrenia (SCZ) has long been recognized as a highly heterogeneous disorder.
Patients differed in their clinical manifestations, prognosis, and underlying …
Patients differed in their clinical manifestations, prognosis, and underlying …